Catalytica Staffing Levels Questioned In FDA Warning Letter

Catalytica expects to be re-inspected by FDA before the end of the year as a follow-up to items identified in an Oct. 29 warning letter to the contract manufacturer.

More from Archive

More from Pink Sheet